Top News
U.S. Spending Up for Cancer Drugs Lacking Evidence of Survival Benefit
Prostate Cancer Observation Varies With MRI, Genomic Testing Availability
FDA Approves Lenalidomide Capsules in 2.5mg, 20mg Strengths
Analysis Ranks Cost Effectiveness of First-Line Therapy Options for Advanced RCC
Downstream Invasive Procedures Occur for 7.4 Percent After Lung Cancer Screen
Trial to Compare Diets in Patients With Leukemia or MDS and Prolonged Neutropenia
Phase 3 Trial Comparing Rituximab Biosimilar and Originator in Follicular Lymphoma
Apalutamide Improves rPFS in Metastatic Castration-Resistant Prostate Cancer
Nonmelanoma Skin Cancers Larger Among Hispanic Patients
42 Percent of Breast Cancer Patients Report Cannabis Use
Urine Analysis May Guide Treatment of Bladder Cancer
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Second Dose of COVID-19 Vaccine Not Enough for Some Patients With Cancer
About half of patients with impaired seroconversion after the first dose of a COVID-19 vaccine still had low antibody levels after the second dose. -
Pandemic-Related Delays in Cancer Surgery May Not Affect Short-Term Outcomes
There was no increase in unresectable disease, new metastatic disease, or 30-day mortality associated with increasing delays. -
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse
More than one-third of tumors sequenced carried a high mutation burden. -
Breast, Prostate Cancer Common in Patients With COVID-19 and Cancer History
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases. -
Adult Participation in Cancer Trials Higher Than Previously Thought
Enrollment rates varied widely by study type and institution. -
Microaggressions and Lack of Tailored Resources: Challenges for LGBTQ+ Patients With Cancer
Survey responses revealed a lack of culturally competent care and tailored resources. -
Eligibility Criteria for Pancreatic Cancer Trials Exclude More Black Patients Than White Patients
Standard eligibility criteria perpetuate racial disparities and are often not medically justifiable, according to researchers. -
Data Hide ‘Critical Disparities’ in Nasopharyngeal Carcinoma Incidence Among Asian Americans
The incidence was highest among Laotian and Chinese Americans. -
First-Line Immunotherapy Continues to Best Chemo in Malignant Pleural Mesothelioma
Data suggest nivolumab plus ipilimumab provides a long-term survival benefit in patients with unresectable malignant pleural mesothelioma.
More Features
How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Medical Billing Outsourcing Is on the Rise
Contracting with outside firms to handle medical billing can be a smart financial move for some medical practices.
Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
Improving Black Representation in Oncology: ‘Be the Change’
Only 3% of medical oncologists in the United States are Black.
Responses to COVID-19 Vaccines in Cancer Patients: Impact of Tumor and Treatment Type
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
- Loading...
Loading...
Loading... 
Loading...